Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities
International Journal of Molecular Sciences · 25.02.2024 · 25 (5) · 2667
DOI: 10.3390/ijms25052667 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.02.2024. Verfasst von Giovanna Gallo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa 1035-1039, 00189 Rome, RM, Italy. Hauptthemen laut MEDLINE: Heart Failure, Mitochondrial Diseases. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health (Ricerca Corrente), by Progetto PRIN 2022, Italian Ministry of Health (Ricerca Corrente), European Union-NextGenerationEU.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Mitochondrial dysfunction, a feature of heart failure, leads to a progressive decline in bioenergetic reserve capacity, consisting in a shift of energy production from mitochondrial fatty acid oxidation to glycolytic pathways. This adaptive process of cardiomyocytes does not represent an effective strategy to increase the energy supply and to restore the energy homeostasis in heart failure, thus contributing to a vicious circle and to disease progression. The increased oxidative stress causes cardiomyocyte apoptosis, dysregulation of calcium homeostasis, damage of proteins and lipids, leakage of mitochondrial DNA, and inflammatory responses, finally stimulating different signaling pathways which lead to cardiac remodeling and failure. Furthermore, the parallel neurohormonal dysregulation with angiotensin II, endothelin-1, and sympatho-adrenergic overactivation, which occurs in heart failure, stimulates ventricular cardiomyocyte hypertrophy and aggravates the cellular damage. In this review, we will discuss the pathophysiological mechanisms related to mitochondrial dysfunction, which are mainly dependent on increased oxidative stress and perturbation of the dynamics of membrane potential and are associated with heart failure development and progression. We will also provide an overview of the potential implication of mitochondria as an attractive therapeutic target in the management and recovery process in heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa 1035-1039, 00189 Rome, RM, Italy.
- IRCCS Neuromed, 86077 Pozzilli, IS, Italy.
- IRCCS San Raffaele Roma, 00166 Rome, RM, Italy.
ORCID-Profile: Giovanna Gallo, Speranza Rubattu
Förderung
- Italian Ministry of Health (Ricerca Corrente), by Progetto PRIN 2022
- Italian Ministry of Health (Ricerca Corrente)
- European Union-NextGenerationEU
Zitieren
APA
Gallo, G., Rubattu, S., & Volpe, M. (2024). Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities. International Journal of Molecular Sciences, 25(5), 2667. https://doi.org/10.3390/ijms25052667
Vancouver
Gallo G, Rubattu S, Volpe M. Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities. International Journal of Molecular Sciences. 2024;25(5):2667. doi:10.3390/ijms25052667
BibTeX
@article{Gallo2024,
author = {Gallo, Giovanna and Rubattu, Speranza and Volpe, Massimo},
title = {Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {5},
pages = {2667},
doi = {10.3390/ijms25052667}
}
EUVIMED